Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity Reactivations, Additional Treatments, and 12-Month Outcomes Article

publication date

  • October 1, 2022

webpage

published in

keywords

  • Bevacizumab
  • Pediatric ophthalmology
  • Retinopathy of prematurity

start page

  • 1120

end page

  • 1128

volume

  • 129

issue

  • 10